SCCS OPINION ON Platinum (nano), Colloidal Platinum (nano) and Acetyl tetrapeptide-17 Colloidal Platinum (nano) - SCCS/1630/21 - Final Opinion - Archive ouverte HAL Accéder directement au contenu
Rapport Année : 2021

SCCS OPINION ON Platinum (nano), Colloidal Platinum (nano) and Acetyl tetrapeptide-17 Colloidal Platinum (nano) - SCCS/1630/21 - Final Opinion

Résumé

. ABSTRACT The SCCS concludes the following: (1) In view of the above, and taking into account the scientific data provided, does the SCCS consider the nanomaterials A (Platinum and Colloidal Platinum ) and B (Acetyl tetrapeptide-17 (and) Colloidal Platinum) are safe when used in leave-on cosmetic products according to the maximum concentrations and specifications reported in the attached list, taking into account reasonably foreseeable exposure conditions? Having considered all the information provided by the Notifiers, and that obtained from other sources, the SCCS is of the opinion that it is not possible to carry out a safety assessment of any of the notified platinum nanomaterials due to limited or missing essential information. The limited amount of data provided by the Notifiers also does not correspond to the requirements and data standards as indicated in the SCCS Guidance (SCCS 1611/19), and the SCCS Memorandum (SCCS/1524/13). To enable safety assessment by the SCCS, the Notifiers need to provide the necessary information, a summary of which is provided in Annex I. (2) Does the SCCS have any further scientific concerns with regard to the use of materials A and B in nano form in cosmetic products? In the absence of sufficient data to allow safety assessment, the SCCS has considered the different aspects of platinum nanomaterials that could raise a concern over consumer safety. As detailed in Annex II, the SCCS has concluded that there is a basis for concern that the use of platinum, colloidal platinum, and acetyl tetrapeptide-17 colloidal platinum (nano) in cosmetic products can pose a risk to the consumer. The SCCS will be ready to assess any evidence provided to support safe use of the materials in cosmetic products. Keywords: SCCS, scientific opinion, Platinum, Colloidal Platinum, Acetyl tetrapeptide-17 Colloidal Platinum, nano, CAS No 7440-06-4, EC No. 231-116-1, Regulation 1223/2009 Opinion to be cited as: SCCS (Scientific Committee on Consumer Safety), Opinion on Platinum (nano), Colloidal Platinum (nano) and Acetyl tetrapeptide-17 Colloidal Platinum (nano), final version of 24-25 June 2021, SCCS/1630/21
Fichier non déposé

Dates et versions

hal-03272423 , version 1 (28-06-2021)

Identifiants

Citer

Ulrike Bernauer, Laurent Bodin, Qasim Chaudhry, Pieter J. Coenraads, Maria Dusinska, et al.. SCCS OPINION ON Platinum (nano), Colloidal Platinum (nano) and Acetyl tetrapeptide-17 Colloidal Platinum (nano) - SCCS/1630/21 - Final Opinion. EW-AQ-22-011-EN-N, Scientific Committee for Consumer Safety (European Commission). 2021. ⟨hal-03272423⟩
84 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More